eff Cancer Research Results
eff, efficacy: Click to Expand ⟱
| Source: |
| Type: |
Power to enhance an anti cancer effect
|
Bladder, Bladder Cancer: Click to Expand ⟱
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
BC, |
MCF-7 |
|
|
|
- |
in-vitro, |
Bladder, |
HTB-22 |
|
|
|
Apoptosis↑, P53↑, iNOS↑, NF-kB↑, Bcl-2↓, ROS↑, SOD↑, TumCCA↑, eff↑, Catalase↑, other↑,
| - |
in-vitro, |
Bladder, |
T24/HTB-9 |
|
|
|
- |
in-vitro, |
BC, |
UMUC3 |
|
|
|
PKM2↓, p‑STAT3↓, TumCG↓, eff↑, chemoP↑, AMPK↑,
eff↑, Apoptosis↑, Casp↑, MMP↓, BID↑, DR5↑, ROS↑, NRF2↑, eff↑, eff↓,
TumCG↓, selectivity↑, *toxicity∅, Necroptosis↑, ROS↑, p62↑, Keap1↑, *NRF2↑, eff↑,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
Catalase↑, 1, Keap1↑, 1, NRF2↑, 1, ROS↑, 3, SOD↑, 1,
Mitochondria & Bioenergetics ⓘ
MMP↓, 1,
Core Metabolism/Glycolysis ⓘ
AMPK↑, 1, PKM2↓, 1,
Cell Death ⓘ
Apoptosis↑, 2, Bcl-2↓, 1, BID↑, 1, Casp↑, 1, DR5↑, 1, iNOS↑, 1, Necroptosis↑, 1,
Transcription & Epigenetics ⓘ
other↑, 1,
Autophagy & Lysosomes ⓘ
p62↑, 1,
DNA Damage & Repair ⓘ
P53↑, 1,
Cell Cycle & Senescence ⓘ
TumCCA↑, 1,
Proliferation, Differentiation & Cell State ⓘ
p‑STAT3↓, 1, TumCG↓, 2,
Immune & Inflammatory Signaling ⓘ
NF-kB↑, 1,
Drug Metabolism & Resistance ⓘ
eff↓, 1, eff↑, 5, selectivity↑, 1,
Functional Outcomes ⓘ
chemoP↑, 1,
Total Targets: 26
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress ⓘ
NRF2↑, 1,
Functional Outcomes ⓘ
toxicity∅, 1,
Total Targets: 2
Scientific Paper Hit Count for: eff, efficacy
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:32 Cells:% prod#:% Target#:961 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page